Investigator-Initiated Research (IIR) supports independent investigators with funding, study drug, or data and samples for research addressing unmet patient needs or important scientific questions.
Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
Investigator Initiated Studies (IIS) supports scientists and clinical researchers pursuing independent clinical, observational, and outcomes research to explore questions or develop new treatment concepts.
Investigator-initiated Research (IIR) and Collaborative Research Grants support external investigators’ studies relevant to Neurocrine’s clinical programs to advance scientific knowledge and improve patient care.
Investigator-Initiated Studies supports independent researchers through Sarepta Therapeutics funding or study materials to answer medical and scientific questions in rare neuromuscular diseases.
Investigator Initiated Studies (IIS) supports investigators and research sponsors conducting clinical studies to deepen understanding of Genentech medicines, improve patient care, and inspire disease research.